TotalPlanta
TotalPlanta develops clinically validated, plant-based therapeutics for xerostomia. Its flagship Spilanthes acmella products are delivered as buccal patches, oral sprays, and lozenges. Core technology includes Tier GMP manufacturing, batch-level traceability, and AI-driven quality control and standardization, enabling consistent, transparent products. Sourcing uses regenerative agriculture in Brazil to combine cost efficiency with ecological integrity. The company aims to scale across antimicrobial, immunology, and women's health applications, establishing a new category of evidence-based botanicals.
TotalPlanta
TotalPlanta develops clinically validated, plant-based therapeutics for xerostomia. Its flagship Spilanthes acmella products are delivered as buccal patches, oral sprays, and lozenges. Core technology includes Tier GMP manufacturing, batch-level traceability, and AI-driven quality control and standardization, enabling consistent, transparent products. Sourcing uses regenerative agriculture in Brazil to combine cost efficiency with ecological integrity. The company aims to scale across antimicrobial, immunology, and women's health applications, establishing a new category of evidence-based botanicals.